Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

530 trials

NCT07609329
Recruiting
Preoperative Immunonutrition in Patients With Bone and Soft Tissue Sarcomas
Not applicable · Czechia · 1 site
Registry update: 27 May 2026
NCT07516925
Recruiting
A Study of Ivonescimab in People With Leiomyosarcoma
Phase 2 · United States · 7 sites
Registry update: 22 Oct 2026
NCT07787429
Recruiting
Evaluation of the Safety and Efficacy of Mifamurtide Versus Standard Treatment With Sorafenib in Patients With High-risk Osteosarcoma
Phase 2 · Poland · 1 site
Registry update: 7 Oct 2026
NCT07774533
Recruiting
68Ga-B7-H3 Nanobody ImmunoPET in Osteosarcoma
Early phase 1 · China · 1 site
Registry update: 19 Aug 2026
NCT07402577
Recruiting
Brief Title Mechanisms of Cancer-Related Pain and Opioid Use Among Adolescents and Young Adult Sarcoma Survivors: Pilot Feasibility Study
Not applicable · United States · 1 site
Registry update: 15 Apr 2026
NCT07467772
Recruiting
Ph 2 Elacestrant in ER Positive Uterine Sarcomas
Phase 2 · United States · 1 site
Registry update: 22 May 2026
NCT07436364
Recruiting
Application of Contrast-enhanced Ultrasound in Monitoring Soft Tissue Sarcoma Response to Neoadjuvant Radiotherapy
Early phase 1 · United States · 1 site
Registry update: 14 Apr 2026
NCT06498648
Recruiting
Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma
Phase 1/2 · United States · 1 site
Registry update: 21 Oct 2026
NCT07501026
Recruiting
Preoperative Spatially Fractionated Radiation Therapy (SFRT) in Soft Tissue Sarcoma (neoSFRT-SARC)
Phase 2 · China · 1 site
Registry update: 30 Mar 2026
NCT07406087
Recruiting
Navigation Intervention for Adolescent and Young Adult Cancer Survivors
Not applicable · United States · 1 site
Registry update: 6 Jul 2026
NCT07477457
Recruiting
A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
Phase 2 · United States · 7 sites
Registry update: 17 Mar 2026
NCT07479732
Recruiting
Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma
Phase 1/2 · China · 1 site
Registry update: 18 Mar 2026
NCT07291297
Recruiting
Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma
Phase 2 · United States · 2 sites
Registry update: 23 Jul 2026
NCT07374848
Recruiting
Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors
Phase 1 · China, United States · 8 sites
Registry update: 23 Jul 2026
NCT07822204
Recruiting
Molecular and Clinical Studies of Bone and Soft Tissue Tumors
Not applicable · Sweden · 1 site
Registry update: 2 Oct 2026
NCT07189871
Recruiting
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Phase 1/2 · United States · 5 sites
Registry update: 1 Oct 2026
NCT07129226
Recruiting
Musculoskeletal Cancers Remote Monitoring and Care
Not applicable · United States · 1 site
Registry update: 6 Aug 2026
NCT07059884
Recruiting
Distance-Based Exercise to Preserve Function and Prevent Disability
Not applicable · United States · 30 sites
Registry update: 4 Nov 2026
NCT06625190
Recruiting
Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
Phase 1/2 · United States · 1 site
Registry update: 30 Jun 2026
NCT07359911
Recruiting
Effect of A Multimodal Exercise Intervention on Chemotherapy Uptake in Newly Diagnosed Pediatric and AYA Sarcoma Patients
Not applicable · United States · 1 site
Registry update: 18 Feb 2026

Ordered by registry start date. Freshness and sponsorship never change the order.